Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

Nearly 10% of postmarket device safety reports in MAUDE were submitted over 6 months after the safety event occurred.

Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...

Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...

Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...

The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...